SCHEMBL9798010

SCHEMBL9798010

NS(=O)(=S)Cc1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.48
CA1 P00915 8/20 0.44
CA9 Q16790 7/20 0.44
CA12 O43570 3/20 0.44
CA7 P43166 2/20 0.44
HTR2A P28223 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
CA4 P22748 1/20 0.42
CA5A P35218 2/20 0.41
IDO1 P14902 2/20 0.41
PLCG1 P19174 1/20 0.41
CA14 Q9ULX7 1/20 0.40
NPC1 O15118 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11137088 0.84 CA2 (0.60) CA2CA1CA9CA12CA7
SCHEMBL8091196 0.79 CA2 (0.67) CA2CA1CA9CA12CA7
SCHEMBL1138688 0.78 PLCG1 (0.46) CA2CA1CA9CA12CA7
SCHEMBL9200717 0.78 PLCG1 (0.46) CA2CA1CA9CA12CA7
SCHEMBL2028261 0.74 PLCG1 (0.43) CA2CA1CA9CA12CA7
SCHEMBL9421744 0.74 FAAH (0.60) CA2CA1CA9CA12CA7
SCHEMBL9629254 0.74 IDO1 (0.43) CA2CA1CA9CA12CA7
SCHEMBL6466 0.74 EGFR (0.43) CA2CA1CA9CA12CA7
SCHEMBL13196 0.74 NPC1 (0.44) CA2CA1CA9CA12CA7
SCHEMBL9000869 0.73 EGFR (0.42) CA2CA1CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252640-B1 ALKANESULFONAMIDES AS ANTIGLAUCOMA AGENTS MERCK & CO. INC. (US) 1991-03-06 EP disclosed
US-4812463-A CARBONIC ANHYDRASE INHIBITORS MERCK & CO., INC. (US) 1989-03-14 US disclosed
EP-0252640-A1 Alkanesulfonamides as antiglaucoma agents MERCK & CO. INC. (US) 1988-01-13 EP disclosed